Literature DB >> 19035889

Risk-adapted use of intravesical chemotherapy.

Seth P Lerner1, Jessie L-S Au.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 19035889     DOI: 10.1111/j.1464-410X.2008.07967.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  2 in total

1.  Intravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts.

Authors:  Minjian Cui; Jessie L-S Au; M Guillaume Wientjes; Michael A O'Donnell; Kevin R Loughlin; Ze Lu
Journal:  J Urol       Date:  2015-02-11       Impact factor: 7.450

Review 2.  Recent advances in the diagnosis and treatment of bladder cancer.

Authors:  Grace Cheung; Arun Sahai; Michele Billia; Prokar Dasgupta; Muhammad S Khan
Journal:  BMC Med       Date:  2013-01-17       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.